Financials
Financial year 2025
VANDEPUTTE MEDICAL BENELUX from Kontich, company number BE0839194312, closed financial year 2025 with a result of € 277,549 after tax. For that financial year VANDEPUTTE MEDICAL BENELUX recorded revenue of € 60,000 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € 531,589 to € 277,549. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 17, 2026.
€ 2.6 million
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 277,549
▼ 48% vs 2024
Profit after tax over the fiscal year.
€ 119,430
▲ 99% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 250,000 paid out
90 % of the profit went to the shareholders, mostly to VANINVEST (100 % of the shares). That is where the money ends up.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9,179
▼ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 108 days on average.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 285,499 | € 318,000 | € 228,000 | € 60,000 | ▼ 74% |
| Profit after taxes | € 910,032 | € 779,192 | € 531,589 | € 277,549 | ▼ 48% |
| Equity | € 2,425,875 | € 2,805,067 | € 2,586,656 | € 2,614,205 | ▲ 1% |
| Total debts | € 526,888 | € 537,808 | € 768,050 | € 1,010,016 | ▲ 32% |
| Cash | € 84,323 | € 77,694 | € 59,945 | € 119,430 | ▲ 99% |
| Retained profit | € 1,925,875 | € 2,305,067 | € 2,086,656 | € 2,114,205 | ▲ 1% |
| Dividend | € 1,000,000 | € 400,000 | € 750,000 | € 250,000 | ▼ 67% |
| Balance sheet total | € 2,952,763 | € 3,342,875 | € 3,354,706 | € 3,624,221 | ▲ 8% |
Key figures of VANDEPUTTE MEDICAL BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to VANDEPUTTE MEDICAL BENELUX?
What happened at VANDEPUTTE MEDICAL BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Vaninvest stepped down as director. NBB
- Leendert Klapwijk stepped down as director. NBB
- Julie Vandeputte stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 277,549 (▼ 48% vs 2024). Source: NBB ↗
- Bart Roscam stepped down as director. NBB
- Bart Roscam became a director. NBB
- Leendert Klapwijk became a director. NBB
- Julie Vandeputte became a director. NBB
In short
From € 910,032 profit in 2022 to € 277,549 profit in 2025.
Paid € 1,210 in corporate taxes since 2022.
Best year ever: 2022, with € 910,032 profit.
Paid out € 2.4 million in dividends to the owners in total.
A new publication or filing at VANDEPUTTE MEDICAL BENELUX? We notify you, reason included.
Follow VANDEPUTTE MEDICAL BENELUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of VANINVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
VANDEPUTTE MEDICAL BENELUXThe shares are held by VANINVEST (100%). It owns 100% of Vandeputte Medical and 100% of Matomedi Holding itself.
Directors
According to the 2025 annual accounts
Bart Roscam
Director
Also active at: DIMEX, VANDEPUTTE SAFETY INTERNATIONAL, VDP SAFETY, GLOBAL SAFETY, CAPITA SELECTA, FULL MOON INVEST, Oak3Capital, CUSTOM SAFETY +5 more
since 2024 · until 2025
Managing director · represented by Walter Vandeputte
Also active at: PASTIS INVEST, ATIRIO, VANDEPUTTE MEDICAL
since 2021 · until 2027
since 2024 · until 2027
since 2022 · until 2027
Shareholders
100%
Participations
100%
Matomedi Holding
100%
Establishments
Establishment units
Physical locations of this company
Antwerpsesteenweg 61
2550 Kontich
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0839.194.312
- VAT number
- BE 0839.194.312
- Registered office
- Antwerpsesteenweg 61, 2550 Kontich
- Names & denominations
- VANDEPUTTE MEDICAL BENELUX · VDP MEDICAL BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 September 2011
- Peppol
- Active · Active since 2 Jun 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Activiteiten van holdings
Holdings